Dicloxacillin
Sponsors
Rigshospitalet, Region Midtjylland, Pfizer, Per Damkier, University of Southern Denmark
Conditions
BacteremiaBacterial InfectionsDrug-drug InteractionEndocarditis InfectiveGram-Positive Bacterial InfectionsHealthyHealthy VolunteersPeriprosthetic joint infection
Phase 1
Phase 3
Phase 4
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
RecruitingNCT05398679
Start: 2022-08-17End: 2027-12-30Target: 360Updated: 2026-02-25
Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.
RecruitingCTIS2023-507617-96-01
Start: 2024-02-14Target: 530Updated: 2025-01-08
The DALBA-study
Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of:
• Health economic costs
• Patient-reported outcomes on quality of life
• Local bone and soft tissue concentrations
• Effect on the gut microbiome
A randomised controlled study of dalbavancin versus standard antibiotic treatment of Gram-positive periprosthetic joint infections.
RecruitingCTIS2025-522088-13-00
Start: 2025-12-12Target: 50Updated: 2025-12-05